SARS coronavirus antibody (Medarex/University of Massachusetts)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSARS coronavirus antibody (Medarex/University of Massachusetts)
Drug Alias Namehumanized mAb (Medarex/University Massachusetts)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSevere Acute Respiratory Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedarex Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Massachusetts Medical SchoolBristol-Myers Squibb CompanyMedarex Inc
Active IndicationsN/A
Inactive IndicationsSevere Acute Respiratory Syndrome

Other Information

ATC CodeN/A
Related LinksN/A